Dermatology
Suspicious Pigmented Lesion — Melanoma Pathway
ABCDE assessment, 2WW referral, and Breslow thickness staging for melanoma
Source: NICE NG14 2015 / BAD
Step 1 of ~10
info
Pigmented Lesion Assessment
Use ABCDE criteria: Asymmetry, Border irregularity, Colour variation, Diameter >6 mm, Evolving (change in size/shape/colour/bleeding). Dermoscopy improves diagnostic accuracy.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Methylene Blue · Guanylate Cyclase / Nitric Oxide Pathway Inhibitor
- Chlorhexidine gluconate with isopropyl alcohol · Skin antiseptic
- Chlorhexidine with cetrimide · Skin antiseptic / wound cleanser
- Barrier creams and ointments · Topical skin protectant
- Cetuximab · Anti-EGFR Monoclonal Antibody — Head and Neck Cancer
- Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
Pathways
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD
- Non-Melanoma Skin Cancer — BCC and SCC · NICE NG12 2015 / BAD NMSC Guidelines
Decision support only. Always apply local guidelines and clinical judgement.